Tum- antigens, TSTA, and T cell immune surveillance.

about

Mutated mitogen-activated protein kinase: a tumor rejection antigen of mouse sarcoma 'Final common pathway' of human cancer immunotherapy: targeting random somatic mutations.

P2860

Q36184608-111E0BE1-B710-4A9A-BBFD-94F9D3FE73E1 Q39136403-45718D05-0F18-4A48-8AA5-E867ACB31F12

P2860

Tum- antigens, TSTA, and T cell immune surveillance.

Item

http://www.wikidata.org/entity/Q36968849

description

1991 nî lūn-bûn

@nan

1991年の論文

@ja

1991年論文

@yue

1991年論文

@zh-hant

1991年論文

@zh-hk

1991年論文

@zh-mo

1991年論文

@zh-tw

1991年论文

@wuu

1991年论文

@zh

1991年论文

@zh-cn

name

Tum- antigens, TSTA, and T cell immune surveillance.

@en

type

Item

label

Tum- antigens, TSTA, and T cell immune surveillance.

@en

prefLabel

Tum- antigens, TSTA, and T cell immune surveillance.

@en

P1476

Tum- antigens, TSTA, and T cell immune surveillance.

@en

P2093

Boon T

http://www.w3.org/2001/XMLSchema#string

Lethé B

http://www.w3.org/2001/XMLSchema#string

Lurquin C

http://www.w3.org/2001/XMLSchema#string

Van Pel A

http://www.w3.org/2001/XMLSchema#string

Van den Eynde B

http://www.w3.org/2001/XMLSchema#string

Warnier G

http://www.w3.org/2001/XMLSchema#string

P2860

The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides

Structure of the gene of tum- transplantation antigen P91A: the mutated exon encodes a peptide recognized with Ld by cytolytic T cells

Structure of the gene of tum- transplantation antigen P198: a point mutation generates a new antigenic peptide

The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice

Immunogenic (tum-) variants of mouse tumor P815: cloning of the gene of tum- antigen P91A and identification of the tum- mutation

Teratocarcinoma cell variants rejected by syngeneic mice: protection of mice immunized with these variants against other variants and against the original malignant cell line.

Tumor cell variants obtained by mutagenesis of a Lewis lung carcinoma cell line: immune rejection by syngeneic mice

A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneous origin

Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. II. T lymphocyte-mediated cytolysis.

Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than immunosuppression

P304

43-51

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1749-6632.1991.TB33437.X

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

636

http://www.w3.org/2001/XMLSchema#string

P577

1991-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

1793230

http://www.w3.org/2001/XMLSchema#string

Tum- antigens, TSTA, and T cell immune surveillance.

about

P2860

P2860

Tum- antigens, TSTA, and T cell immune surveillance.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698